amyloid PET
-
A4 study, ADNI, Alzheimer’s disease, amyloid PET, blood biomarker, Brain, calibration, cognition, machine learning, negative predictive value, Neurodegenerative Diseases, p-tau217, plasma biomarkersAlzheimer’s Blood Biomarker Models Lose Rule-Out Power Across Cohorts
A 2026 ADNI/A4 validation study found that Alzheimer’s plasma-biomarker machine-learning models still…
-
A-beta 42/40, Alzheimer’s disease, amyloid PET, blood biomarkers, Brain, Clarity AD, cognition, GFAP, lecanemab, maintenance dosing, Neurodegenerative Diseases, p-tau181, PK/PD modelingLecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment…
